Iconovo receives grant of SEK 680,000 from Innowwide for market efforts in South Korea

Iconovo announces that the company will receive a grant of SEK 680,000 from Innowwide. The grant will be used to carry out a market study to introduce the company’s services and products to the South Korean market. The project will be carried out during the period April to September 2024 and is part of the Iconovo Accelerator program that the company has previously communicated.

“Our contacts with South Korean companies show great interest and potential for the development of inhaled drugs. The grant from Innowwide now gives us the opportunity to establish ourselves in one of the world’s most interesting markets for drug development,” says Johan Wäborg, CEO of Iconovo.

To read the full press release, please click here